细胞活力检测市场规模、份额及成长分析（按产品、应用、最终用户和地区划分）－产业预测（2026-2033）

预计到 2024 年，细胞活力检测市场规模将达到 16.7 亿美元，到 2025 年将达到 18.4 亿美元，到 2033 年将达到 39.2 亿美元，在预测期（2026-2033 年）内，复合年增长率为 9.94%。

细胞活力显示是否存在活细胞，是细胞健康的关键指标，尤其是在受到毒性等化学和物理因素影响时。细胞活力检测 (CVA) 对于评估细胞对病原体和药物的反应至关重要，并在製药和医疗保健行业中具有广泛的潜在应用。目前，受药物研发领域日益增长的关注，细胞活力检测市场正经历强劲成长。这些检测在药物研发的早期阶段发挥关键作用，能够评估化合物的功效、毒性和安全性。对创新治疗方法的持续需求，以及不断发展的製药生物技术产业，正显着推动对细胞活力检测的需求，并凸显其在现代生物医学研究中的重要性。

细胞活力检测市场驱动因素

细胞活力检测市场正在成长，主要得益于製药公司持续加大研发投入，致力于开发针对各种疾病的新药治疗方法。製药和生物技术产业高度依赖细胞活力检测来促进药物发现、评估毒性并评估新治疗方法的疗效。这些领域的持续创新推动了对能够提供准确可靠数据的先进检测方法的需求。这种对先进检测方法的依赖不仅促进了药物发现过程，也凸显了细胞活力检测在现代医学研究和治疗方法进步中的关键作用。

细胞活力检测市场限制因素

细胞活力检测市场面临许多挑战，其中最主要的原因是所需设备的高成本，这对新兴医疗机构和预算有限的公司而言构成了重大障碍。此外，缺乏能够操作这些先进仪器的合格专业人员和技术人员也加剧了这个问题。有限的资金使得中小企业难以聘请熟练人员，从而阻碍了它们有效利用这些检测方法，并抑制了整体市场成长。因此，这些限制阻碍了细胞活力检测领域的潜在进步和创新。

细胞活力检测市场趋势

细胞活力检测市场正经历强劲成长，这主要得益于技术的不断进步和创新。製造商正在加速整合人工智慧 (AI) 和机器学习等先进技术，以提升数据分析和解读能力。这种协同效应不仅提高了检测的准确性和效率，还拓宽了其在各种研究和临床环境中的应用范围。此外，数据分析能力的提升也推动了更复杂、更易用的检测系统的开发，从而促进了整个市场的发展。这一趋势标誌着细胞研究和开发正朝着更智慧化和自动化的解决方案转变。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 一手和二手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析和影响

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 专利分析
• 价值链分析
• 用例分析
• 客户和购买标准分析
• PESTEL 分析
• 总体经济指标
• 市场吸引力指数

全球细胞活力检测市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 消耗品
• 装置

全球细胞活力检测市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 基础研究
• 干细胞研究
• 药物发现与开发
• 临床和诊断用途
• 其他的

全球细胞活力检测市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 学术研究机构
• 製药和生物技术公司
• 医院和诊断实验室
• 其他的

全球细胞活力检测市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • GCC
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• F. Hoffmann-La Roche AG
• Danaher Corporation
• Lonza Group AG
• Promega Corporation
• Charles River Laboratories International, Inc.
• Menarini Silicon Biosystems, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Macrogen Inc
• DiscoverX Corporation
• Corning Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Perkinelmer, Inc.
• Biognosys
• Cell Signaling Technology, Inc.
• Lebermuth, Inc.
• Eurofins DiscoverX Products
• GE Healthcare
• Beckman Coulter,Inc.

结论与建议

Cell Viability Assays Market size was valued at USD 1.67 Billion in 2024 and is poised to grow from USD 1.84 Billion in 2025 to USD 3.92 Billion by 2033, growing at a CAGR of 9.94% during the forecast period (2026-2033).

Cell viability, indicating the presence of living cells, serves as a crucial marker of cellular health, particularly influenced by chemical or physical events such as toxicity. Cell viability assays (CVAs) are essential for evaluating the cellular responses to pathogens or pharmaceuticals, leading to extensive applications within the pharmaceutical and medical industries. The market for cell viability assays is currently experiencing robust growth, driven by the heightened focus on drug development. These assays are instrumental in early-stage drug discovery, enabling the assessment of compound efficacy, toxicity, and safety profiles. The continuous need for innovative therapies, paired with the expanding pharmaceutical and biotechnology sectors, is significantly propelling the demand for cell viability assays, highlighting their importance in modern biomedical research.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Viability Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Viability Assays Market Segments Analysis

Global Cell Viability Assays Market is segmented by Product, application, end user and region. Based on Product, the market is segmented into Consumables, Instruments. Based on application, the market is segmented into Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, Other Applications. Based on end user, the market is segmented into Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cell Viability Assays Market

The Cell Viability Assays market is experiencing growth driven by ongoing investments in research and development by manufacturers aiming to create new pharmaceutical treatments for diverse health conditions. The pharmaceutical and biotechnology industries heavily rely on cell viability assays to facilitate drug discovery, assess toxicity, and evaluate the effectiveness of new therapies. As innovation continues within these fields, there is an increasing demand for sophisticated assays that can provide accurate and reliable data. This reliance on advanced testing methods not only enhances the drug development process but also underscores the critical role of cell viability assays in modern medical research and therapeutic advancements.

Restraints in the Cell Viability Assays Market

The cell viability assays market faces significant challenges due to the high costs associated with the necessary instruments, which poses a considerable barrier for emerging medical providers and companies operating with restricted budgets. Additionally, the shortage of qualified professionals and technical experts to operate these advanced instruments further exacerbates the issue. Limited financial resources make it difficult for smaller enterprises to afford hiring skilled personnel, thereby hindering their ability to effectively utilize these assays and stifling overall market growth. As a result, these constraints are impeding the potential advancements and innovations within the cell viability sector.

Market Trends of the Cell Viability Assays Market

The Cell Viability Assays market is experiencing robust growth driven by continuous technological advancements and innovations. Manufacturers are increasingly integrating these assays with cutting-edge technologies such as artificial intelligence (AI) and machine learning, enhancing data analysis and interpretation capabilities. This synergy not only improves the accuracy and efficiency of assays but also expands their applications across various research and clinical settings. Additionally, the ability to leverage data analytics is fostering the development of more sophisticated and user-friendly assay systems, thereby propelling the overall market forward. The trend signifies a shift towards more intelligent, automated solutions in cell-based research and drug development.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• Customer & Buying Criteria Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Market Attractiveness Index

Global Cell Viability Assays Market Size byProduct & CAGR (2026-2033)

• Market Overview
• Consumables
• Instruments

Global Cell Viability Assays Market Size byApplication & CAGR (2026-2033)

• Market Overview
• Basic Research
• Stem Cell Research
• Drug Discovery & Development
• Clinical & Diagnostic Applications
• Other Applications

Global Cell Viability Assays Market Size by End User & CAGR (2026-2033)

• Market Overview
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Hospital and Diagnostic Laboratories
• Other End Users

Global Cell Viability Assays Market Size & CAGR (2026-2033)

• North America, (Product, Application, End User)
  • US
  • Canada
• Europe, (Product, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• F. Hoffmann-La Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Silicon Biosystems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiscoverX Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perkinelmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biognosys
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lebermuth, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins DiscoverX Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter,Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation